Cargando…

Comparing the efficacy of tocilizumab with corticosteroid therapy in treating COVID-19 patients: a systematic review and meta-analysis

PURPOSE: Tocilizumab has shown equivocal outcomes in reducing mortality in COVID-19. The corticosteroids appear to be an affordable alternative to tocilizumab. This study aims to estimate the efficacy of tocilizumab and the corticosteroids particularly dexamethasone and methylprednisolone and to ide...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lim, Phei Ching, Wong, Kar Loon, Rajah, Retha, Chong, Meng Fei, Chow, Ting Soo, Subramaniam, Sivasangari, Lee, Chong Yew
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2022
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8792140/ https://www.ncbi.nlm.nih.gov/pubmed/35084705 http://dx.doi.org/10.1007/s40199-021-00430-8

Ejemplares similares

Systematic Review and Meta-Analysis of Diabetes Knowledge among Type 2 Diabetes Patients in Southeast Asia
por: Lim, Phei Ching, et al.
Publicado: (2021)

Candidemia in COVID‐19 treated with corticosteroids and tocilizumab
por: Yamamoto, Koichiro, et al.
Publicado: (2021)

Long‐term outcomes in corticosteroid‐refractory Graves' orbitopathy treated with tocilizumab
por: Moi, Laura, et al.
Publicado: (2021)

Health Literacy-Related Knowledge, Attitude, and Perceived Barriers: A Cross-sectional Study among Physicians, Pharmacists, and Nurses in Public Hospitals of Penang, Malaysia
por: Rajah, Retha, et al.
Publicado: (2017)

A Case of Abdominal Perforation in a COVID+ Patient Treated With Tocilizumab and Corticosteroids
por: Chaudhry, Bilal, et al.
Publicado: (2023)

A Recovered Case of COVID-19 Myocarditis and ARDS Treated With Corticosteroids, Tocilizumab, and Experimental AT-001
por: Coyle, Justin, et al.
Publicado: (2020)

The Use of Corticosteroids or Tocilizumab in COVID-19 Based on Inflammatory Markers
por: Rubio-Rivas, Manuel, et al.
Publicado: (2021)

Beneficial effect of corticosteroids in preventing mortality in patients receiving tocilizumab to treat severe COVID-19 illness
por: Rubio-Rivas, Manuel, et al.
Publicado: (2020)

Intestinal perforation in patient with COVID-19 infection treated with tocilizumab and corticosteroids. Report of a clinical case()
por: Gonzálvez Guardiola, Paula, et al.
Publicado: (2021)

The efficacy of corticosteroid‐sparing immunomodulatory therapy in treating patients with central multifocal choroiditis
por: de Groot, Evianne L., et al.
Publicado: (2020)

Development and validation of patient diabetes knowledge questionnaire (PDKQ)
por: Lim, Phei Ching, et al.
Publicado: (2023)

Case Study: A Patient with Asthma, Covid-19 Pneumonia and Cytokine Release Syndrome Treated with Corticosteroids and Tocilizumab
por: Schleicher, Gunter K, et al.
Publicado: (2020)

Tocilizumab/unspecified corticosteroids: Spinal epidural abscess: 2 case report
Publicado: (2020)

Maternal and perinatal guideline development in hospitals in South East Asia: results from the SEA-ORCHID project
por: Thinkhamrop, Jadsada, et al.
Publicado: (2009)

Date of Admission during COVID-19 Pandemic Impacted Patient Outcomes in Addition to the Higher Efficacy of Tocilizumab Plus High-Dose Corticosteroid Therapy Compared to Tocilizumab Alone
por: Belhassen-García, Moncef, et al.
Publicado: (2021)

Severe Adult-onset Still Disease with Constrictive Pericarditis and Pleuritis That Was Successfully Treated with Tocilizumab in Addition to Corticosteroids and Cyclosporin A
por: Kawaguchi, Hoshimi, et al.
Publicado: (2017)

Corticosteroid Plus Tocilizumab in COVID-19: When Two Is Better Than One
por: Kow, Chia Siang, et al.
Publicado: (2021)

Combined therapy of tocilizumab and corticosteroids in severe SARS-CoV-2 disease()
por: González-Castro, A., et al.
Publicado: (2022)

What’s next after metformin? focus on sulphonylurea: add-on or combination therapy
por: Lim, Phei C., et al.
Publicado: (2015)

Corticosteroids/tocilizumab: Reactivation of Mycobacterium tuberculosis following off-label therapy: case report
Publicado: (2020)

Effect of tocilizumab, sarilumab, and baricitinib on mortality among patients hospitalized for COVID-19 treated with corticosteroids: a systematic review and meta-analysis
por: Albuquerque, Arthur M., et al.
Publicado: (2023)

Efficacy and safety of tocilizumab in Korean patients with active rheumatoid arthritis
por: Baek, Han Joo, et al.
Publicado: (2019)

Tocilizumab and Systemic Corticosteroids in the Management of Patients with COVID-19: A Systematic Review and Meta-Analysis
por: Alkofide, Hadeel, et al.
Publicado: (2021)

Clinical effect of early administration of tocilizumab following the initiation of corticosteroid therapy for patients with COVID-19()
por: Kawamata, Takaya, et al.
Publicado: (2022)

Tocilizumab in Combination with Corticosteroids in COVID-19 Pneumonia: A Single-Centre Retrospective Controlled Study
por: Kardos, Zsófia, et al.
Publicado: (2023)

Mortality Rates Among Hospitalized Patients With COVID-19 Infection Treated With Tocilizumab and Corticosteroids: A Bayesian Reanalysis of a Previous Meta-analysis
por: Albuquerque, Arthur M., et al.
Publicado: (2022)

Efficacy of the early treatment with tocilizumab-hydroxychloroquine and tocilizumab-remdesivir in severe COVID-19 Patients
por: Sarhan, Rania M., et al.
Publicado: (2022)

Administration Timing and Efficacy of Tocilizumab in Patients With COVID-19 and Elevated IL-6
por: Li, Pan, et al.
Publicado: (2021)

SAT-580 Tocilizumab Improvement in a Patient with Corticosteroid Resistant Thyroid Orbitopathy: Report of a Case
por: Coy, Andres, et al.
Publicado: (2019)

Impact of the Addition of Baricitinib to Standard of Care Including Tocilizumab and Corticosteroids on Mortality and Safety in Severe COVID-19
por: Masiá, Mar, et al.
Publicado: (2021)

539. Impact of Corticosteroids when Combined with Tocilizumab or Remdesivir for the Treatment of Severe SARS-CoV-2
por: Rosati, Michael, et al.
Publicado: (2021)

Use of tocilizumab and sarilumab alone or in combination with corticosteroids for covid-19: systematic review and network meta-analysis
por: Zeraatkar, Dena, et al.
Publicado: (2022)

Safety and Efficacy of Tocilizumab for the Treatment of Rheumatoid Arthritis
por: Ogata, Atsushi, et al.
Publicado: (2012)

Efficacy of Tocilizumab in Patients Hospitalized with Covid-19
por: Stone, John H., et al.
Publicado: (2020)

Efficacy and safety of tocilizumab in COVID-19 patients
por: Zheng, Kai-Lian, et al.
Publicado: (2020)

Cortisone/tocilizumab: Lack of efficacy: case report
Publicado: (2021)

Tocilizumab: Lack of efficacy: 10 case reports
Publicado: (2021)

Methylprednisolone/tocilizumab: Lack of efficacy: case report
Publicado: (2021)

Tocilizumab and COVID-19: Timing of Administration and Efficacy
por: Abidi, Emna, et al.
Publicado: (2022)

A 46-Year-Old Woman with a 4-Year History of Graves Disease, with Severe Corticosteroid-Unresponsive Thyroid Eye Disease, Successfully Treated with Tocilizumab
por: Almazrouei, Ohood, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_gqv31vfieqlh401v4d88t66s2d